文献速递甲状腺疾病性腺与生殖内分泌

格雷夫斯病患者放射性碘治疗后两年内妊娠的新生儿甲亢发生率

Incidence of Neonatal Hyperthyroidism Among Newborns of Graves' Disease Patients Treated with Radioiodine Therapy.
PubMed 文献 · Thyroid · 2018-12-18

该回顾性研究纳入145例放射性碘治疗后两年内妊娠的格雷夫斯病患者,新生儿甲亢发生率为5.5%(8/145)。多因素分析显示孕晚期TRAb值是新生儿甲亢的唯一危险因素,预测界值为9.7 IU/L。

要点

  • 放射性碘治疗后两年内妊娠者新生儿甲亢发生率为5.5%。
  • 孕晚期TRAb值是新生儿甲亢的唯一危险因素。
  • 孕晚期TRAb预测新生儿甲亢的界值为9.7 IU/L。

核心结论

  • 放射性碘治疗后两年内妊娠的格雷夫斯病患者,其新生儿甲亢发生率为5.5%。

研究设计与样本

  • 回顾性研究,纳入145例放射性碘治疗后两年内妊娠的格雷夫斯病患者并收集新生儿信息。

主要发现

  • 145例孕妇中54例(37%)在孕早期因母体甲亢接受抗甲状腺药物或碘化钾治疗。
  • 8例新生儿发生甲亢,发生率5.5%,其中7例母亲孕期接受抗甲状腺药物或碘化钾治疗。
  • 放射性碘治疗后6-12个月、12-18个月、18-24个月妊娠者的新生儿甲亢发生率分别为8.8%、5.5%、3.6%。
  • 多因素分析显示孕晚期TRAb值是新生儿甲亢的唯一危险因素。

关键数值与推荐

  • 孕晚期TRAb预测新生儿甲亢的界值为9.7 IU/L(参考值<2.0 IU/L)。

临床怎么用

  • 孕晚期TRAb值高的格雷夫斯病患者妊娠期应由产科医生密切随访胎儿。
  • 此类母亲的新生儿出生后应由儿科医生密切随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The serum thyrotropin receptor antibody (TRAb) titers of Graves' disease (GD) patients are known to increase after radioiodine (RAI) therapy, and they can remain high for years. The incidence of neonatal hyperthyroidism (NH) among newborns of mothers with GD who conceived after RAI therapy has not been previously reported. The aims of this study were to investigate the incidence of NH among newborns of mothers who conceived within two years after RAI therapy, and to identify predictors of NH. METHODS: GD patients (n = 145) who conceived within two years after RAI therapy were retrospectively reviewed, and information regarding their newborns was collected. RESULTS: Of the 145 pregnant women, 54 (37%) were treated with antithyroid drugs or potassium iodide for maternal hyperthyroidism during the first trimester. There were eight newborns with NH, resulting in an incidence of 5.5%. Seven of the eight mothers whose newborns had NH were treated with antithyroid drugs or potassium iodide during their pregnancy. The incidence of NH among the newborns of mothers who conceived within 6-12 months after RAI therapy was 8.8%, within 12-18 months was 5.5%, and within 18-24 months was 3.6%. Multivariate analysis revealed that the TRAb values in the third trimester were the only risk factor for NH. The cutoff TRAb value in the third trimester for predicting NH was 9.7 IU/L (reference value <2.0 IU/L). CONCLUSIONS: The incidence of NH among newborns of mothers who conceived within two years after RAI therapy was 5.5%. The fetuses of pregnant GD patients whose TRAb value is high in the third trimester should be carefully followed by an obstetrician during pregnancy, and the newborns should be carefully followed by a pediatrician after birth.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Yoshihara A, Iwaku K, Noh JY, et al. Incidence of Neonatal Hyperthyroidism Among Newborns of Graves' Disease Patients Treated with Radioiodine Therapy. Thyroid. 2018. PMID: 30426886. doi:10.1089/thy.2018.0165

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。